$SILO
Silo Pharma, Inc.

2013 Q4 Form 10-K Financial Statement

#000121390014002019 Filed on March 31, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2013 2012 Q4
Revenue -$20.88K $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $20.00K $70.00K $10.00K
YoY Change 100.0% 75.0% 0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $20.00K $70.00K $10.00K
YoY Change 100.0% 75.0% 0.0%
Operating Profit
YoY Change
Interest Expense $100.0K $100.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $80.00K $30.00K -$10.00K
YoY Change -900.0% -175.0% 0.0%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $80.00K $30.00K -$10.00K
YoY Change -900.0% -175.0% 0.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.06 $0.04 -$0.02
COMMON SHARES
Basic Shares Outstanding 32.44M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.210M $2.210M $0.00
YoY Change
Cash & Equivalents $2.010M $2.010M $0.00
Short-Term Investments $200.0K $200.0K $0.00
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.210M $2.210M $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$2.616K $0.00 $279.00
YoY Change -1037.63%
TOTAL ASSETS
Total Short-Term Assets $2.210M $2.210M $0.00
Total Long-Term Assets -$2.616K $0.00 $279.00
Total Assets $2.207M $2.210M $279.00
YoY Change 791077.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $0.00 $20.00K
YoY Change -100.0% -100.0%
Accrued Expenses $0.00 $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $20.00K $20.00K $20.00K
YoY Change 0.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.00K $20.00K $40.00K
YoY Change -50.0% -50.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $20.00K $20.00K $40.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $18.72K $20.00K $41.47K
YoY Change -54.87% -50.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $4.061K $3.063K
YoY Change 32.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.789M $2.190M -$40.00K
YoY Change
Total Liabilities & Shareholders Equity $2.207M $2.210M $279.00
YoY Change 791077.06%

Cashflow Statement

Concept 2013 Q4 2013 2012 Q4
OPERATING ACTIVITIES
Net Income $80.00K $30.00K -$10.00K
YoY Change -900.0% -175.0% 0.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$120.0K -$180.0K $0.00
YoY Change 800.0% -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 870.0K 2.190M 0.000
YoY Change 10850.0%
NET CHANGE
Cash From Operating Activities -120.0K -180.0K 0.000
Cash From Investing Activities
Cash From Financing Activities 870.0K 2.190M 0.000
Net Change In Cash 750.0K 2.010M 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$120.0K -$180.0K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 gldsw Percentage Of Net Assets
PercentageOfNetAssets
1.00 pure
CY2012Q4 us-gaap Assets
Assets
279 USD
CY2013Q4 us-gaap Assets
Assets
2207384 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
20691 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2050 USD
CY2012Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
782 USD
CY2013Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1667 USD
CY2012Q4 us-gaap Liabilities
Liabilities
41473 USD
CY2013Q4 gldsw Unrealized Investment Gains Losses
UnrealizedInvestmentGainsLosses
65143 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
4061 USD
CY2013Q4 us-gaap Liabilities
Liabilities
18717 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
400000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
3063 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1123497 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2919449 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
1167754 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
1167754 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1788667 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
279 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2207384 USD
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30631200 shares
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30631200 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
shares
CY2012Q4 us-gaap Interest Receivable
InterestReceivable
USD
CY2013Q4 us-gaap Interest Receivable
InterestReceivable
600 USD
CY2012Q4 us-gaap Notes Payable
NotesPayable
20000 USD
CY2013Q4 us-gaap Notes Payable
NotesPayable
15000 USD
CY2012Q4 gldsw Accumulated Net Investment Gain Loss
AccumulatedNetInvestmentGainLoss
USD
CY2013Q4 gldsw Accumulated Net Investment Gain Loss
AccumulatedNetInvestmentGainLoss
-71986 USD
CY2012Q4 gldsw Investments In Non Affiliates
InvestmentsInNonAffiliates
USD
CY2013Q4 gldsw Investments In Non Affiliates
InvestmentsInNonAffiliates
196164 USD
CY2012Q4 gldsw Accumulated Undistributed Net Realized Gain Or Loss
AccumulatedUndistributedNetRealizedGainOrLoss
USD
CY2013Q4 gldsw Accumulated Undistributed Net Realized Gain Or Loss
AccumulatedUndistributedNetRealizedGainOrLoss
39754 USD
CY2012Q4 gldsw Net Asset Value Per Share
NetAssetValuePerShare
CY2013Q4 gldsw Net Asset Value Per Share
NetAssetValuePerShare
0.04
CY2013Q4 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
39754 USD
CY2013Q4 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
84014 USD
CY2011 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.00
CY2012 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.00
CY2013 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32436953 shares
CY2013Q4 us-gaap Assets Net
AssetsNet
1788667 USD
CY2013Q4 us-gaap Investment Income Net
InvestmentIncomeNet
600 USD
CY2013Q4 us-gaap Net Investment Income
NetInvestmentIncome
-20883 USD
CY2013Q4 gldsw Investment Income Net Per Share
InvestmentIncomeNetPerShare
0
CY2013Q4 gldsw Net Investment Income Per Share
NetInvestmentIncomePerShare
0
CY2013Q4 gldsw Realized Investment Gains Losses Per Share
RealizedInvestmentGainsLossesPerShare
0
CY2013Q4 gldsw Increase Decrease In Operating Assets Per Share
IncreaseDecreaseInOperatingAssetsPerShare
0
CY2013Q4 gldsw Unrealized Investment Gains Losses Per Share
UnrealizedInvestmentGainsLossesPerShare
0
CY2013 gldsw Fair Value Investments Entities That Calculate Net Asset Value Per Share Beginning
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareBeginning
-0.00
CY2013 gldsw Fair Value Investments Entities That Calculate Net Asset Value Per Share Realized And Unrealized Gain
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRealizedAndUnrealizedGain
-0.00
CY2013 gldsw Fair Value Investments Entities That Calculate Net Asset Value Per Share Net Investment Loss
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareNetInvestmentLoss
0.00
CY2013 gldsw Fair Value Investments Entities That Calculate Net Asset Value Per Share Net Increase Decrease In Net Assets Resulting From Operations
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareNetIncreaseDecreaseInNetAssetsResultingFromOperations
0.00
CY2013 gldsw Fair Value Investments Entities That Calculate Net Asset Value Per Share Issuance Of Common Stock
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareIssuanceOfCommonStock
0.05
CY2013 gldsw Fair Value Investments Entities That Calculate Net Asset Value Per Share Offering Costs From Issuance Of Common Stock
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareOfferingCostsFromIssuanceOfCommonStock
-0.01
CY2013 gldsw Fair Value Investments Entities That Calculate Net Asset Value Per Share Net Increase Decrease In Net Assets From Capital Stock Transactions
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareNetIncreaseDecreaseInNetAssetsFromCapitalStockTransactions
0.04
CY2013 gldsw Fair Value Investments Entities That Calculate Net Asset Value Per Share Ending
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareEnding
0.04
CY2013 gldsw Common Stock Market Price Per Share
CommonStockMarketPricePerShare
CY2013Q4 gldsw Common And Preferred Stock Shares Outstanding
CommonAndPreferredStockSharesOutstanding
40606200 shares
CY2013 gldsw Ratio Of Operating Expenses To Average Net Assets
RatioOfOperatingExpensesToAverageNetAssets
0.1440 pure
CY2013 gldsw Ratio Of Net Investment Loss To Average Net Assets
RatioOfNetInvestmentLossToAverageNetAssets
-0.1428 pure
CY2013 gldsw Weighted Average Debt Per Common Share
WeightedAverageDebtPerCommonShare
0.00
CY2013 gldsw Return Based On Change In Net Asset Value During Period Description
ReturnBasedOnChangeInNetAssetValueDuringPeriodDescription
not meaningful
CY2012Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
USD
CY2013Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
-65143 USD

Files In Submission

Name View Source Status
0001213900-14-002019-index-headers.html Edgar Link pending
0001213900-14-002019-index.html Edgar Link pending
0001213900-14-002019.txt Edgar Link pending
0001213900-14-002019-xbrl.zip Edgar Link pending
eisner.jpg Edgar Link pending
eisnerlogo.jpg Edgar Link pending
f10k2013ex31ii_pointcapital.htm Edgar Link pending
f10k2013ex31i_pointcapital.htm Edgar Link pending
f10k2013ex32ii_pointcapital.htm Edgar Link pending
f10k2013ex32i_pointcapital.htm Edgar Link pending
f10k2013_pointcapital.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gldsw-20131231.xml Edgar Link completed
gldsw-20131231.xsd Edgar Link pending
gldsw-20131231_cal.xml Edgar Link unprocessable
gldsw-20131231_def.xml Edgar Link unprocessable
gldsw-20131231_lab.xml Edgar Link unprocessable
gldsw-20131231_pre.xml Edgar Link unprocessable
img01.jpg Edgar Link pending
img02.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending